These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
96 related items for PubMed ID: 16138263
1. Blockade of angiotensin II type 1 receptor diminishes cardiac hypertrophy, but does not abolish thyroxin-induced preconditioning. Pantos C, Paizis I, Mourouzis I, Moraitis P, Tzeis S, Karamanoli E, Mourouzis C, Karageorgiou H, Cokkinos DV. Horm Metab Res; 2005 Aug; 37(8):500-4. PubMed ID: 16138263 [Abstract] [Full Text] [Related]
6. Angiotensin II type 1-receptor antagonism prevents type IIA secretory phospholipase A2-dependent lipid peroxidation. Luchtefeld M, Bandlow N, Tietge UJ, Grote K, Pfeilschifter J, Kaszkin M, Beck S, Drexler H, Schieffer B. Atherosclerosis; 2007 Sep; 194(1):62-70. PubMed ID: 17069818 [Abstract] [Full Text] [Related]
7. Increased vulnerability of hypertrophied myocardium to ischemia and reperfusion injury. Relation to cardiac renin-angiotensin system. Zhang Y, Xu S. Chin Med J (Engl); 1995 Jan; 108(1):28-32. PubMed ID: 7712835 [Abstract] [Full Text] [Related]
8. Effects of the AT1 receptor blocker candesartan on myocardial ischemia/reperfusion in isolated rat hearts. Songur CM, Songur MO, Kocabeyoglu SS, Basgut B. Heart Surg Forum; 2014 Oct 01; 17(5):E263-8. PubMed ID: 25367240 [Abstract] [Full Text] [Related]
10. Effects of angiotensin II type 1 receptor antagonist and temperature on prolonged cardioplegic arrest in neonatal rat myocytes. Lucchese G, Cambi GE, De Rita F, Franzoi M, Faggian G, Mazzucco A, Modesti PA, Luciani GB. Artif Organs; 2013 Aug 01; 37(8):689-94. PubMed ID: 23638632 [Abstract] [Full Text] [Related]
11. A potential role for angiotensin II in obesity induced cardiac hypertrophy and ischaemic/reperfusion injury. du Toit EF, Nabben M, Lochner A. Basic Res Cardiol; 2005 Jul 01; 100(4):346-54. PubMed ID: 15821998 [Abstract] [Full Text] [Related]
16. Pharmacological concentration of angiotensin-(1-7) activates NADPH oxidase after ischemia-reperfusion in rat heart through AT1 receptor stimulation. Oudot A, Vergely C, Ecarnot-Laubriet A, Rochette L. Regul Pept; 2005 Apr 15; 127(1-3):101-10. PubMed ID: 15680476 [Abstract] [Full Text] [Related]
17. Effects of AT1 receptor blockade on renal injury and mitogen-activated protein activity in Dahl salt-sensitive rats. Nishiyama A, Yoshizumi M, Rahman M, Kobori H, Seth DM, Miyatake A, Zhang GX, Yao L, Hitomi H, Shokoji T, Kiyomoto H, Kimura S, Tamaki T, Kohno M, Abe Y. Kidney Int; 2004 Mar 15; 65(3):972-81. PubMed ID: 14871417 [Abstract] [Full Text] [Related]
18. Renin-angiotensin system and myocardial collagen matrix: modulation of cardiac fibroblast function by angiotensin II type 1 receptor antagonism. Brilla CG, Scheer C, Rupp H. J Hypertens Suppl; 1997 Dec 15; 15(6):S13-9. PubMed ID: 9493122 [Abstract] [Full Text] [Related]
19. Ischemia/reperfusion injury is increased and cardioprotection by a postconditioning protocol is lost as cardiac hypertrophy develops in nandrolone treated rats. Penna C, Tullio F, Perrelli MG, Moro F, Abbadessa G, Piccione F, Carriero V, Racca S, Pagliaro P. Basic Res Cardiol; 2011 May 15; 106(3):409-20. PubMed ID: 21174210 [Abstract] [Full Text] [Related]
20. Maternal hyperthyroidism increases the susceptibility of rat adult offspring to cardiovascular disorders. Lino CA, da Silva IB, Shibata CE, Monteiro Pde S, Barreto-Chaves ML. Mol Cell Endocrinol; 2015 Nov 15; 416():1-8. PubMed ID: 26277399 [Abstract] [Full Text] [Related] Page: [Next] [New Search]